NBIONascent BiotechNBIO info
$0.05info0.00%24h
Global rank33538
Market cap$5.58M
Change 7d14.88%
YTD Performance-73.83%
SP500 benchmarkUnderperform
P/E-2.35
P/S0
Revenue$0
Earnings-$2.80M
Dividend yield-
Main Sector
Healthcare

Nascent Biotech NBIO Operating Margins

Operating Margin in 2021: -0.46%

According to Nascent Biotech latest financial reports the company has an operating margin of -0.46%, an decrease of -75.52% to 2021. At the end of 2021 company had an operating margin of -1.87%.

Nascent Biotech Operating Margin from 2021 to 2024

-
Value:-

NBIO Operating Margin History by year

YearOperating MarginChange
2022-0.46%-75.52%
2021-1.87%-

View the highest operating margin companies arrow right

logo
Facebook Icon
Twitter Icon
Linkedin Icon
Β© 2024 Topstocks.org